Dr. Ligon on Delivering CAR T-cell Therapy via Mediport Lines in Pediatric B-Cell Malignancies
John Ligon, MD, assistant professor, Department of Pediatrics, the University of Florida College of Medicine, discusses findings from a study investigating the use of mediports to deliver CAR T-cell therapy in patients at Pediatric Real-World CAR Consortium (PRWCC) medical centers.